Nippon India BSE Sensex Next 30 Index Fund - Regular Plan-Growth Option

  • Scheme Category:  
  • Other Scheme >  
  • Index Funds
NAV: ₹ 10.2141 ↓ -1.17%
[as on 23 January, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Nippon India BSE Sensex Next 30 Index Fund - Regular Plan-Growth Option -3.41% -1.17% -3.07% -2.33% -1.59%-----

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.86% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 0.14%

Equity

NameSymbol / ISINSectorWeight %
Hindalco Industries LimitedHINDALCO (INE038A01020)Non - Ferrous Metals4.83%
InterGlobe Aviation LimitedINDIGO (INE646L01027)Transport Services4.83%
JSW Steel LimitedJSWSTEEL (INE019A01038)Ferrous Metals4.44%
Grasim Industries LimitedGRASIM (INE047A01021)Cement & Cement Products4.37%
Shriram Finance LimitedSHRIRAMFIN (INE721A01047)Finance4.13%
Oil & Natural Gas Corporation LimitedONGC (INE213A01029)Oil3.95%
Jio Financial Services LimitedJIOFIN (INE758E01017)Finance3.94%
Bajaj Auto LimitedBAJAJ-AUTO (INE917I01010)Automobiles3.94%
Eicher Motors LimitedEICHERMOT (INE066A01021)Automobiles3.81%
Nestle India LimitedNESTLEIND (INE239A01024)Food Products3.60%
Coal India LimitedCOALINDIA (INE522F01014)Consumable Fuels3.51%
SBI Life Insurance Company LimitedSBILIFE (INE123W01016)Insurance3.50%
Hindustan Aeronautics LimitedHAL (INE066F01020)Aerospace & Defense3.48%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology3.41%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services3.36%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology3.32%
Vedanta LimitedVEDL (INE205A01025)Diversified Metals3.29%
HDFC Life Insurance Company LimitedHDFCLIFE (INE795G01014)Insurance3.13%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services3.06%
Tata Consumer Products LimitedTATACONSUM (INE192A01025)Agricultural Food & other Products3.02%
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology2.89%
Britannia Industries LimitedBRITANNIA (INE216A01030)Food Products2.73%
Wipro LimitedWIPRO (INE075A01022)IT - Software2.70%
Tata Power Company LimitedTATAPOWER (INE245A01021)Power2.67%
Adani Enterprises LimitedADANIENT (INE423A01024)Metals & Minerals Trading2.61%
The Indian Hotels Company LimitedINDHOTEL (INE053A01029)Leisure Services2.60%
Varun Beverages LimitedVBL (INE200M01039)Beverages2.52%
Power Finance Corporation LimitedPFC (INE134E01011)Finance2.32%
IndusInd Bank LimitedINDUSINDBK (INE095A01012)Banks2.06%
REC LimitedRECLTD (INE020B01018)Finance1.84%
Portfolio data is as on date 31 October, 2025

NAV (Net asset value) history

Nippon India BSE Sensex Next 30 Index Fund - Regular Plan-Growth Option - 30 days NAV history

DateNAV
23 January, 202610.2141
22 January, 202610.3350
21 January, 202610.2289
20 January, 202610.2538
19 January, 202610.4613
16 January, 202610.5374
14 January, 202610.5629
13 January, 202610.5329
12 January, 202610.5400
9 January, 202610.4708
8 January, 202610.5687
7 January, 202610.7528
6 January, 202610.7681
5 January, 202610.6970
2 January, 202610.6903
1 January, 202610.5744
31 December, 202510.5285
30 December, 202510.4155
29 December, 202510.3997
26 December, 202510.4409
24 December, 202510.4545
23 December, 202510.4579
22 December, 202510.4278
19 December, 202510.3270
18 December, 202510.2328
17 December, 202510.1928
16 December, 202510.2198
15 December, 202510.2768
12 December, 202510.2827
11 December, 202510.2089

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Nippon India BSE Sensex Next 30 Index Fund - Regular Plan-Growth Option?
    The latest NAV of Nippon India BSE Sensex Next 30 Index Fund - Regular Plan-Growth Option is 10.2141 as on 23 January, 2026.
  • What are YTD (year to date) returns of Nippon India BSE Sensex Next 30 Index Fund - Regular Plan-Growth Option?
    The YTD (year to date) returns of Nippon India BSE Sensex Next 30 Index Fund - Regular Plan-Growth Option are -3.41% as on 23 January, 2026.